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  11 
Abstract 12 
Sheep, cows, cats, and rabbits are kept by humans for agricultural purposes and as 13 
companion animals. Much of the mammary research in these species has focussed on 14 
mastitis in the case of ruminants and rabbits, and mammary tumourigenesis in cats 15 
and rabbits. However, similarities with the human breast suggest that these species 16 
may be currently underutilised as valuable comparative models of breast development 17 
and disease. The mammary gland undergoes cyclical postnatal development that will 18 
be considered here in the context of these non-traditional model species, with a focus 19 
on the mammary microenvironment at different postnatal developmental stages. The 20 
second part of this review will consider mammary tumour development. Ruminants 21 
are thought to be relatively ‘resistant’ to mammary tumourigenesis, likely due to 22 
multiple factors including functional properties of ruminant mammary 23 
stem/progenitor cells, diet, and/or the fact that production animals undergo a first 24 
parity soon after puberty. By contrast, unneutered female cats and rabbits have a 25 
propensity to develop mammary neoplasms, and subsets of these may constitute 26 
valuable comparative models of breast cancer. 27 
 28 
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  30 
1. Introduction 31 
Sheep, cows, cats and rabbits represent a spectrum of species that are kept by humans 32 
for agricultural purposes and as companion animals. Much of the mammary research 33 
in these species has focussed on mastitis in the case of ruminants and rabbits, and 34 
mammary tumourigenesis in cats and rabbits. However, similarities with the human 35 
breast suggest that these species may be valuable comparative models of breast 36 
development and disease.  37 
 38 
The mammary gland has a particularly fascinating cycle of postnatal development that 39 
will be considered here in the context of the sheep, cow, cat and rabbit, with an 40 
emphasis on the mammary microenvironment at different postnatal developmental 41 
stages. The second part of this review will focus on mammary tumour development in 42 
these species. In particular, the apparent ‘resistance’ of ruminants to mammary 43 
tumourigenesis will be explored and contrasted with the propensity of unneutered 44 
female cats and rabbits to develop mammary neoplasia. The value of mammary 45 
carcinomas arising in cats and rabbits as comparative models of breast cancer will be 46 
evaluated. 47 
 48 
2. Sheep 49 
The ovine mammary gland has two mammae each with one galactophore and ductal 50 
system [1]. Supernumerary teats may be present, and larger supernumerary teats tend 51 
to exhibit anatomical complexity including a teat canal and/or teat cistern in which 52 
milk may accumulate, potentially predisposing to mastitis [2]. The mammary 53 
parenchyma is characterised by the presence of terminal duct lobular units (TDLUs) 54 
supported by collagenous intra- and interlobular stroma [1]. The collagenous stroma 55 
of the ovine mammary gland is strikingly similar to the human breast and is in 56 
contrast to the adipocyte-rich stroma of the mouse [3] (Fig. 1). 57 
 58 
Sheep are polyoestrous seasonal breeders, with a cycle length of 14-20 days and the 59 
occurrence of oestrus cycling controlled by decreasing photoperiod. Ovulation occurs 60 
towards the end of oestrus. Gestation length is approximately 150 days [4]. 61 
 62 
2.1. Ovine pre- and peri-pubertal mammary development 63 
A striking 20% of ovine mammary growth, based on dried fat-free tissue weights, 64 
occurs between birth and the beginning of pregnancy [5]. Sheep reach puberty at 6 to 65 
8 months old. Growth through the pre-pubertal period is not linear and is punctuated 66 
by a phase of allometric mammary development, when the rate of growth of the 67 
mammary gland exceeds that of the body as a whole. Delineation of the timing of the 68 
period of allometric growth is likely affected by study design, including method of 69 
determining growth rate, sheep breed [6], and body condition. One study suggests that 70 
ovine mammary allometric growth occurs between 3 and 4 months of age [5].  71 
 72 
Using DNA content of the mammary gland as a surrogate read-out for mammary 73 
growth, other authors have demonstrated that the magnitude of mammary allometric 74 
growth is perhaps counter-intuitively increased in lambs receiving rations designed to 75 
give a low rate of weight gain compared to those receiving a higher plane of nutrition. 76 
These data suggest that rations designed to produce high weight gain can result in a 77 
decrease the rate of mammary allometric growth of pre-pubertal lambs [7].  78 
 79 
During the pre-gestational phase of ovine mammary development, expression of 80 
insulin-like growth factor-I mRNA, a likely mammary paracrine mitogen, 81 
approximately mirrors the period of allometric growth [8]. Experiments in 82 
ovariectomised lambs have demonstrated that the pre-pubertal period of allometric 83 
growth is not dependent on ovarian hormones [9] and expression of insulin-like 84 
growth factor-I mRNA is unaffected by ovariectomy [8]. However, when exogenous 85 
oestrogen is administered to ovariectomised ewes, expression of insulin-like growth 86 
factor-I mRNA in the mammary fat pad adjacent to the parenchyma is increased [8] 87 
suggesting some degree of hormonal regulation. There is differential regulation of 88 
expression of insulin-like growth factor-I and II. Expression of insulin-like growth 89 
factor-II is again higher during the first period of postnatal growth, up to 23 weeks of 90 
age, but parenchymal mRNA expression increases following ovariectomy and 91 
expression in both the parenchyma and mammary fat pad adjacent to the parenchyma 92 
is suppressed by administration of exogenous oestrogen [8]. 93 
 94 
Expression of another mammary mitogen, keratinocyte growth factor, has also been 95 
assessed in ovine mammary tissue. The mammary stroma expresses two transcripts of 96 
keratinocyte growth factor mRNA, whereas only one transcript is identifiable in the 97 
mammary parenchyma, hinting at a possible paracrine mode of action for this factor 98 
in ovine mammary development, and underlining the importance of the mammary fat 99 
pad in participating in cross-talk with the epithelial compartment [1, 10]. Expression 100 
of the neurotrophin growth factors, nerve growth factor and brain derived 101 
neurotrophic factor, is higher in pre-pubertal mammary gland compared to later 102 
developmental time points and may also contribute to local regulation of mammary 103 
development [11]. 104 
 105 
2.2. Ovine mammary development during gestation and lactation 106 
The udder volume of a pregnant ewe may increase exponentially over the last month 107 
before lambing [12]. Based on assessment of dried fat-free tissue weights, 80% of 108 
ovine mammary growth is associated with pregnancy, and mammary growth is 109 
essentially complete by parturition [5]. As would be anticipated, this phase of growth 110 
during pregnancy is accompanied by Ki67 expression in mammary epithelial cells, 111 
with a Ki67 proliferation index of approximately 8% recorded in late gestation. 112 
Interestingly, in ewes approximately 10 days prior to lambing, increased Ki-67 113 
expression is observed in smaller diameter “immature” alveoli than in alveoli with a 114 
large lumen and a correspondingly attenuated epithelium, suggesting that smaller 115 
alveoli may contribute to a final pulse of mammary growth prior to parturition [13].  116 
 117 
During this late gestational phase of rapid epithelial proliferation, the mammary 118 
parenchymal area increases dramatically but the proportion of mammary gland area 119 
occupied by parenchyma does not alter, allowing inference that the mammary fat pad 120 
volume increases in parallel. In ewes with cleared contralateral fat pads, this increase 121 
in fat pad volume is not observed in the contralateral cleared fat pad, again 122 
highlighting interplay between the mammary epithelial compartment and the fat pad 123 
[14]. 124 
 125 
Milk yield in sheep is proportional to number of offspring, and the placenta is thus 126 
considered to be pivotal in the control of this dramatic phase of gestational mammary 127 
development [1, 15]. Placental lactogen has been implicated in this regulation, with 128 
concentration of placental lactogen correlating with udder size pre-partum and post-129 
partum milk yield [16].  130 
 131 
Leptin is a hormone, classically associated with synthesis by adipocytes, that 132 
influences energy balance and food intake. It is also expressed by the mammary gland 133 
and may modulate cellular proliferation and differentiation, although many of the 134 
studies demonstrating such activities have utilised in vitro systems, or 135 
supraphysiological doses of leptin [17]. In the ovine mammary gland, leptin mRNA 136 
levels are high at the beginning and end of gestation and are lower during mid-137 
pregnancy and lactation [18]. Whilst the role of leptin in the mammary gland is yet to 138 
be fully elucidated, it seems likely to be involved in regulating mammary growth and 139 
function during phases of development necessitating metabolic adaptation, such as 140 
late pregnancy and early lactation [17]. 141 
 142 
A more recent study has focussed on the transcriptional changes occurring during late 143 
gestation compared to early lactation using RNA-seq. In late pregnancy, key 144 
biological processes include cell proliferation, beta-oxidation of fatty acids, and 145 
translation, translation elongation, and translation initiation [19]. STAT5 genes 146 
(STAT5A and STAT5B) are expressed more highly during late pregnancy than in 147 
lactation [19]. This may reflect the role of STAT5 in mammary lobuloalveolar 148 
development and upregulation of milk protein gene expression [20]. It may also point 149 
to a relatively less important role of STAT5 in regulating milk protein gene 150 
expression in sheep, similar to that suggested in cows [19, 21]. However, this finding 151 
and associated implications must be interpreted with caution as STAT5 may be 152 
regulated predominantly through protein activation rather than by transcription [22]. 153 
Of historical note, one of the original papers describing STAT5, then termed milk 154 
protein binding factor, discovered it to be highly expressed in the mammary glands of 155 
sheep [23]. 156 
 157 
RNA seq also identifies changes in the expression of epigenetic regulators, 158 
particularly chromatin remodellers, between pregnancy and lactation. This suggests 159 
that epigenetic regulation may contribute to coordination of the considerable 160 
transcriptional changes required when the mammary gland undergoes transition from 161 
a pregnancy ‘growth and development’ phase to a lactational ‘synthesis and secretion’ 162 
phenotype [19]. 163 
  164 
2.3. Ovine post-lactational mammary gland involution 165 
As in other species, ovine post-lactational mammary gland involution may be 166 
initiated, in both experimental and natural settings, by either abrupt or gradual 167 
cessation of lactation [24]. Ultrasonography allows visualisation of a transient 168 
increase in gland cistern volume following abrupt weaning. At approximately one 169 
week of involution, milk clots are appreciable within the gland cistern, and these 170 
accumulations are likely gradually resorbed, leading to a reduction in gland cistern 171 
volume as involution progresses [25]. 172 
 173 
In rodent models involution is a bipartite process comprising waves of epithelial cell 174 
death, and subsequent removal of these dead cells, coupled with stromal remodeling 175 
[26]. During ovine involution, there is evidence of apoptosis [13, 27]. Although 176 
apoptosis has long been appreciated as one cell death mechanism occurring during 177 
mammary involution [28], more recent studies in mice have revealed that murine 178 
involution can proceed in the absence of executioner caspases 3 and 6, and that Stat3-179 
regulated lysosomal-mediated cell death is a critical cell death pathway [29-31]. The 180 
contribution of lysosomal-mediated cell death to ovine post-lactational mammary 181 
regression is yet to be established. 182 
 183 
Efferocytosis, the removal of dead, damaged, or superfluous cells by neighbouring 184 
cells or professional phagocytes [32], is an important facet of involution. During 185 
murine mammary involution, epithelial cells contribute to efferocytosis [33] and we 186 
and others have documented the importance of immune cells, particularly 187 
macrophages, in the murine mammary microenvironment [34-40]. Similarly, 188 
mammary epithelial cells and macrophages are effectors of efferocytosis during ovine 189 
mammary involution [41-44]. 190 
 191 
During involution, ovine basal mammary epithelial cells, or myoepithelial cells, 192 
appear to undergo morphological changes similar to those observed in the mouse, 193 
with shrinkage and re-direction of the cellular processes [38, 42]. There is also 194 
ultrasonographic evidence of stromal remodeling in the involuting ovine mammary 195 
gland [25].  196 
 197 
In an agricultural context, ovine mammary involution may be initiated as an abrupt or 198 
gradual process, according to the production system. It is important to note that when 199 
lambs being raised for meat production are removed synchronously from dams at the 200 
production stage termed ‘weaning’, a variable degree of natural weaning will have 201 
already occurred. As a result, ovine mammary tissue sampled at the production stage 202 
termed ‘weaning’ frequently exhibits variable, but often profound, levels of 203 
regression (author’s unpublished results) (Fig. 1). In experimental mice, cell death 204 
also occurs during involution induced by natural weaning although there is a slower 205 
onset of this process compared to during involution induced by forced synchronous 206 
litter removal [45]. 207 
 208 
3. Cattle 209 
The bovine mammary gland has four inguinal mammae each with one galactophore 210 
and ductal system [26]. The arrangement of TDLUs and the mammary stroma is 211 
broadly similar to the sheep and thus also to the human breast [1, 3]. In the bovine 212 
mammary gland some authors favour the term terminal ductal units to the descriptor 213 
TDLUs [46].  214 
 215 
Cattle are polyoestrous and have an oestrous cycle of 18-24 days. Ovulation occurs 216 
approximately 10-12 hours after the end of oestrus. Gestation length varies according 217 
to breed but is frequently in the region of 279-290 days [4]. 218 
 219 
3.1. Bovine pre- and peri-pubertal mammary development 220 
Pre-gestational mammary development in heifers partially shapes future lactation 221 
potential. The reader is directed to a recent review examining the importance of this 222 
developmental phase in the context of future productivity [47]. This section will focus 223 
firstly on comparison to ovine pre-gestational development and secondly on recent 224 
observations regarding the mammary microenvironment during this phase. 225 
 226 
In contrast to the lamb, ovariectomy in the heifer perturbs mammary growth [48]. In 227 
dairy heifers undergoing ovariectomy, mammary epithelial progesterone receptor 228 
expression is considerably reduced and the intensity of oestrogen receptor expression 229 
is decreased. There is reduced Ki67 expression in both the mammary epithelial cells 230 
and the stroma [49]. 231 
 232 
There is clear recognition of the importance of immune cells in coordinating 233 
mammary development in mice [37, 38, 50-55]. Compared to laboratory rodents, 234 
there is very little known about immune cell regulation of mammary development in 235 
the cow. However, localization of immune cells in female calves up to 42 days old 236 
hints at a similarly important role in this species, with significantly more 237 
macrophages, mast cells, and eosinophils present in ‘near stroma’ within 100-150 238 
microns of mammary epithelium, than in the more distant ‘far stroma’ [56].  239 
 240 
In addition to immune cells, myoepithelial cells are also attracting increasing attention 241 
as cellular players that may impact development of the pre-pubertal bovine mammary 242 
gland [47]. In 100 day old calves, more numerous myoepithelial cells are detectable in 243 
individuals that have been ovariectomised than in intact heifers. In the former it is 244 
suggested that oestrogen may negatively regulate myoepithelial differentiation and 245 
that, in the absence of oestrogen, more abundant myoepithelial cells may constrain 246 
luminal epithelial proliferation [57]. However, in calves receiving tamoxifen, in 247 
which there is an ensuing 50% reduction in mammary growth, fewer myoepithelial 248 
cells are noted [58]. It seems likely that the role of myoepithelial cells in the 249 
developing mammary gland is currently under-appreciated and this is likely to be a 250 
focus of future research efforts [47].  251 
 252 
3.2. Bovine mammary development during gestation and lactation 253 
The majority of mammary growth is achieved during the final trimester of pregnancy. 254 
As in the sheep, placental lactogen (see also Section 2.2) is considered likely to be 255 
important in regulating this growth [59]. To a lesser degree, prolactin is also likely 256 
important [1]. When quantification of mammary DNA is used as a surrogate read-out 257 
of udder size, it correlates poorly with milk yield in lactating dairy cows [59]. 258 
 259 
Historically it has been noted that in early lactation in the murine mammary gland 260 
cells active in DNA synthesis do not undergo mitosis. Thus it was postulated that 261 
there is an amplification of genomic DNA in order to increase the number of gene 262 
copies to support the high rate of RNA and protein synthesis in lactating epithelial 263 
cells [60-62]. A more recent study has revealed that approximately 40% of the 264 
luminal alveolar epithelial cells in the bovine mammary gland during late gestation 265 
are binucleated. It has been suggested that these may increase milk production 266 
capacity [63] or represent a downstream sequel to the DNA synthesis required to 267 
sustain lactation  [62] (Fig. 2). 268 
 269 
During lactation, there is concomitant epithelial cell death and the proportion of 270 
epithelial cells is therefore highest at 90 days lactation and then declines [64]. 271 
Interestingly, when once daily milking is carried out unilaterally in dairy cows, with 272 
the other half of the udder milked twice a day, epithelial proliferation decreases and 273 
cell death increases in the half that is milked once a day. These observations, together 274 
with related transcriptional changes, suggest that local factors and milk build-up 275 
regulate the decrease in milk yield associated with once daily milking [65]. Such 276 
experiments echo those in mice, where unilateral teat sealing has been utilised to 277 
study the first stage of post-lactational regression and has demonstrated that cell death 278 
is induced by local factors, presumably associated with accumulation of milk [66].  279 
 280 
3.3. Bovine post-lactational mammary gland involution 281 
Although some of the comments relating to ovine post-lactational mammary 282 
regression (Section 2.3) are applicable to cows, there are specific features of bovine 283 
involution that are noteworthy. Several different methods of reducing milking and 284 
modulating nutritional intake may be employed to induce involution [67]. Many cows 285 
are already in late pregnancy at the point of involution or ‘drying off’, and these 286 
animals therefore exhibit what we have previously termed a ‘parallel pregnancy’ 287 
involution signature [26]. In mice undergoing forced involution, the degree of cell 288 
death is reduced when there is concurrent pregnancy [68]. However, there is earlier 289 
onset of cell death in mice that undergo natural weaning whilst pregnant [45]. Overall, 290 
the process of involution in mice that are concurrently pregnant differs notably from 291 
the progression of involution in non-pregnant mice in terms of tissue histo-292 
morphology, cell death dynamics, and gene expression patterns [45]. Similarly one of 293 
the key features of the bovine mammary microenvironment in cows with a ‘parallel 294 
pregnancy’ involution signature is that there is dual evidence of cell death and cell 295 
renewal, and the importance of the latter is underlined by the suggestion that dairy 296 
cows undergo ‘regenerative involution’ [46, 69, 70]. 297 
 298 
Through use of murine models, post-lactational regression has been demonstrated to 299 
be a two-stage process. The first stage is reversible and even though there is extensive 300 
cell death, suckling of pups can successfully recommence if the offspring are returned 301 
during this phase. The second stage, from approximately 48 hours onwards, is 302 
irreversible and comprises further cell death and tissue remodelling [20]. 303 
Interestingly, experiments in cows subject to an abrupt discontinuation of milking at 304 
mid lactation, demonstrate that after seven days of non-milking, milking can be 305 
reinitiated with almost comparable milk yield and composition to that observed prior 306 
to induction of involution [71]. Involution appears to be partially reversible following 307 
11 days of involution [72] suggesting that this time point may be approaching the 308 
transition to irreversibility. 309 
 310 
As already described (Section 2.3) Stat3 activation is fundamental to the progression 311 
of murine mammary involution [29-31] and the available evidence supports a similar 312 
role in bovine involution. As in other species, the pattern of bovine involution is 313 
somewhat heterogeneous, and phosphorylated STAT3 (pSTAT3) is detectable in the 314 
bovine mammary gland within 36 hours of abrupt cessation of milking at mid 315 
lactation in samples with low level of milk protein expression [73]. Robust expression 316 
of pSTAT3 is detectable by 72 hours of involution [74].  317 
 318 
4. Domestic cats 319 
Cats generally have four pairs of mammae, each with multiple ductal trees [75]. The 320 
feline mammary gland can be considered to have terminal duct lobular units [76]. 321 
 322 
Cats are seasonally polyoestrous long day seasonal breeders, with a cycle length of 323 
14-21 days. Cats are induced ovulators, with ovulation occurring 24-48 hours after 324 
breeding or equivalent stimulus. Gestation length is approximately 65 days [4]. 325 
 326 
4.1. Feline pre- and peri-pubertal mammary development 327 
Compared to farm animals, there has been less focus on pre- and peri-pubertal 328 
mammary development in cats. At puberty, oestrogen stimulates mammary epithelial 329 
proliferation [75]. Progesterone, increasing in levels during dioestrus and later 330 
pregnancy, likely elicits mammary production of growth hormone, and concomitant 331 
synthesis of insulin-like growth factors, that have also been implicated in the process 332 
of feline mammogenesis [75, 77, 78]. Correspondingly, feline mammary tissue 333 
exhibits progesterone receptor and oestrogen receptor expression [79] [80-82]. 334 
Histological changes associated with the oestrus cycle have been described in the 335 
mammary gland of dogs and are likely to also occur in the mammary gland of cats 336 
although it should be noted that, unlike dogs, cats are induced ovulators [75, 83, 84]. 337 
 338 
4.2. Feline mammary development during gestation and lactation 339 
To the author’s knowledge, there is very little species-specific information regarding 340 
the development of the mammary gland during pregnancy and lactation in the cat. 341 
Interestingly, the whey protein beta-lactoglobulin that is found in the milk of many 342 
species except humans, rodents, and lagomorphs, exists in three forms in the cat and 343 
the cat possesses at least two distinct beta-lactoglobulin genes, compared to the cow 344 
that has one [85] [86]. 345 
 346 
4.3. Feline post-lactational mammary gland involution 347 
There is a relative paucity of information regarding the specific features of post-348 
lactational mammary regression in the cat. However, patterns of canine mammary 349 
involution have been described, and potentially similar morphological changes may 350 
arise in the cat. Historically post-lactational alveolar regression has been suggested to 351 
commence from ten days post partum, with complete regression achieved by 40 days 352 
post partum [87] but more recently authors have described morphological evidence of 353 
canine involution from day 56 of lactation, with almost complete involution achieved 354 
by the end of the third month of lactation. In the latter study, the authors suggested a 355 
likelihood for involution to start slightly earlier in cranial mammae that are less 356 
preferred for sucking by pups [88].  357 
 358 
5. Rabbits 359 
The rabbit usually has four pairs of mammae, with one thoracic pair, two abdominal 360 
pairs and one inguinal pair [26]. There are six or seven ductal systems per mamma 361 
[89]. The rabbit mammary gland has a terminal duct lobular unit structure [90]. 362 
 363 
Wild rabbits are seasonally polyoestrous long day seasonal breeders, with a suggested 364 
cycle length of 16-18 days. However, the oestrus cycle is less well-defined in some 365 
domestic rabbits. Rabbits are induced ovulators, with ovulation occurring 10-13 hours 366 
after breeding or equivalent stimulus. Gestation length is approximately 31-32 days 367 
[91]. 368 
 369 
5.1. Leporine pre- and peri-pubertal mammary development 370 
Consistent with use of rabbits as a laboratory model, much of the work concerning 371 
pre- and peri-pubertal mammary development in rabbits has focussed on the impact of 372 
diet. Consumption of an obesogenic diet between 8-13 weeks of age significantly 373 
alters the composition of the mammary gland, when assessed at gestation day 8 of a 374 
subsequent pregnancy. There is increased deposition of adipose tissue, and a relative 375 
reduction in the percentage of the gland composed of connective tissue and 376 
epithelium. Interestingly, there is also less epithelial proliferative activity, as 377 
measured by Ki67 immunofluorescence [92]. By contrast, when an obesogenic diet is 378 
administered from prior to puberty to mid-pregnancy, the proportion of epithelium is 379 
significantly higher at mid pregnancy than in control animals [93]. Extending the 380 
period of abnormal diet by raising newborn rabbits on lactating dams fed an 381 
obesogenic diet and then maintaining such a diet for the offspring from the onset of 382 
puberty and throughout early pregnancy also results in abnormal mammary tissue 383 
when sampled at day 8 of pregnancy. Rabbits maintained on this regimen exhibit 384 
ectatic mammary ducts containing proteinaceous material and disorganisation of 385 
mammary alveolar structures [94]. 386 
 387 
5.2. Leporine mammary development during gestation and lactation 388 
In contrast to the sheep, where the majority of mammary growth occurs during 389 
gestation, and growth is essentially completed by parturition, historical analyses of 390 
mammary gland DNA content in New Zealand white rabbits indicate that 67% of 391 
growth occurs during gestation and 33% in lactation [95]. Gestation length in the 392 
rabbit is 31-32 days, and the majority of pregnancy-associated mammary gland 393 
growth occurs between gestation days 16 and 26 [95]. Growth dynamics are likely 394 
influenced by breed and the experimental methodologies employed. By measuring 395 
mammary gland weight as a percentage of body weight in Dutch Belted rabbits, other 396 
authors have suggested that approximately 30-40% of total mammary gland growth is 397 
attained during pregnancy with the remaining 60-70% occurring in lactation [96]. 398 
Thus, a notable degree of mammary growth occurs during both pregnancy and 399 
lactation in the rabbit although the projected relative contributions of each 400 
developmental stage may vary between studies. Corroborating this assertion, we have 401 
demonstrated multifocally abundant Ki67 expression in luminal mammary epithelial 402 
cells during both pregnancy and lactation in the rabbit [89]. This is in contrast to the 403 
mouse in which the majority of epithelial proliferation occurs in association with 404 
pregnancy rather than lactation [97, 98]. 405 
 406 
In contrast to the sheep where leptin expression is higher in early and late pregnancy 407 
than in lactation [18] (see Section 2.2), in the rabbit mammary gland, leptin exhibits 408 
low levels of mRNA expression during pregnancy, but increases significantly 409 
between days 3 and 16 of lactation in luminal epithelial cells. It has been suggested to 410 
have autocrine or paracrine regulatory functions [99]. 411 
 412 
The presence and potential significance of binucleated mammary epithelial cells in 413 
the udder of the cow has already been discussed (see Section 3.2). Similarly, we have 414 
observed binucleated luminal epithelial cells in both mammary alveoli and sinus-like 415 
dilatations of the mammary milk ducts during lactation in the rabbit [89].  416 
 417 
Limited studies have examined the mammary microenvironment in rabbits during 418 
pregnancy and lactation. We have identified a population of CD3-positive T 419 
lymphocytes that are present both in stromal clusters and also in intraepithelial foci, 420 
suggesting exocytosis into the milk, and implying a contribution to the mucosal 421 
immune system of the gland in this species [89]. We have also observed macrophages 422 
in the rabbit mammary gland, particularly in association with impaired mammary 423 
development tentatively linked with abdominal ectopic pregnancy [100]. Rabbits are 424 
notable for being a species in which ectopic pregnancy is relatively frequently 425 
reported [101] and we and others have observed cases of retarded mammary 426 
development in rabbits that have a concurrent abdominal ectopic pregnancy [100, 427 
102]. 428 
 429 
5.3. Leporine post-lactational mammary gland involution 430 
By involution day 14 in the rabbit, mammary gland weight expressed as a percentage 431 
of body weight is 0.5% and is similar to that recorded in the virgin animal. 432 
Unfortunately the timing of induction of involution, if forced involution was initiated, 433 
is unclear from these experiments [96].  In rabbits in which synchronous involution is 434 
initiated by removal of the young at day 14 of lactation (day 0 involution), prolactin 435 
receptor numbers decrease from 10 days of involution [103].  436 
 437 
In other systems, rabbit mammary gland involution may proceed by means of natural 438 
weaning (see Section 2.3). In this scenario, milk yield reduces from the fourth week 439 
although does may continue to lactate for a further 2-4 weeks. It is noteworthy that 440 
does may have a ‘parallel pregnancy and lactation signature’ at this time. Milk yield 441 
peaks more rapidly and then drops more precipitously in female rabbits that are bred 442 
soon after parturition than those in which breeding is delayed until 35-56 days after 443 
parturition [91]. 444 
 445 
6. Comparative mammary tumourigenesis in the sheep, cow, cat, and rabbit 446 
There are striking species differences in susceptibility to development of mammary 447 
tumours. Mammary tumours are the third most common tumour type in cats [104, 448 
105] (Fig. 3). In a recent survey 11% of neoplasms detected in European shorthaired 449 
cats were of mammary origin, and of these, 97.3% were malignant [106]. This is in 450 
concordance with a previous study suggesting that these tumours carry a poor 451 
prognosis, with a malignant:benign ratio of 9:1 [107]. Classification of feline 452 
mammary tumours [75, 108] and prognostic markers [109, 110] are considered 453 
elsewhere and will not be described further here. Not dissimilar to cats, a recent 454 
investigation in rabbits found mammary adenocarcinoma to be the second most 455 
frequently diagnosed neoplasm [111].  456 
 457 
By contrast, mammary tumours in sheep and cows are rare, even in populations of 458 
animals attaining advanced age [112, 113]. Quantification of contemporary incidence 459 
of mammary neoplasia in ruminants is challenging due to the scarcity of cases, 460 
frequently limited to single case reports [113-117]. However, a large study of autopsy 461 
and biopsy specimens from goats revealed interesting data. This survey of 1146 462 
caprine specimens revealed that 100 goats that were presented with neoplasia 463 
(totalling 102 neoplasms), and of these, 7 submissions (approximately 0.6% of all 464 
submissions), comprised mammary neoplasia [118].  465 
 466 
The purpose of this section is illuminate interesting facets of mammary 467 
tumourigenesis in the species in question. The following sections will examine 468 
potential reasons why mammary tumours are rare in sheep and cows (Section 6.1), 469 
and the utility of feline and leporine mammary tumours as models of human breast 470 
cancer (Sections 6.2 and 6.3.1 respectively). 471 
 472 
6.1. Mammary tumourigenesis in sheep and cows: a rare event 473 
As already stated (Section 6), mammary tumours in sheep and cows are rare. 474 
Interestingly, reports in sheep document the occurrence of benign mammary 475 
adenomas [115] and fibroadenomas [117], and low grade carcinomas known to have 476 
been present for some time, suggesting slow clinical progression [113]. By contrast, 477 
in cows mammary carcinomas metastatic to draining lymph nodes have been recorded 478 
[114, 116] and historically reviewed [119] and in some cases, more distant metastatic 479 
spread has also been noted [116, 119]. Primary mammary epithelial neoplasms in the 480 
sheep and cow therefore cannot be assumed to have the same clinical behaviour and a 481 
more malignant phenotype is tentatively suggested for a subset of bovine mammary 482 
neoplasms. 483 
 484 
The rarity of mammary neoplasms in ruminants raises the interesting broader question 485 
regarding the reasons for variable susceptibility to cancer development in different 486 
mammals. Peto’s Paradox encompasses the notion that large and long-lived species 487 
do not develop more neoplasms although dogma suggests that these mammals would 488 
accrue a greater number of somatic mutational ‘hits’ and thus develop more tumours 489 
[120]. Whilst mechanisms such as the evolution of multiple copies of the TP53 gene 490 
in the elephant [121] partially account for this paradox, it remains poorly understood.  491 
 492 
On possible explanation for the differential susceptibility of the mammary gland to 493 
neoplastic transformation in different species is that the properties of mammary 494 
stem/progenitor cells (MaS/PCs) vary in different species. Differences in MaS/PCs 495 
between species may impact tumourigenesis because long-lived, self-renewing 496 
MaS/PCs are considered to be a potential cell of origin for mammary neoplasia [122].  497 
 498 
Bovine MaS/PCs have been historically described as “morphologically distinct pale-499 
staining cells” [123, 124]. When bromodeoxyuridine was administered to prepubertal 500 
heifers, these cells accounted for approximately 40% of the bromodeoxyuridine 501 
positive population in spite of comprising only 10% of the epithelial population [123]. 502 
Subsequently, a number of groups have used various techniques to attempt 503 
identification and isolation of bovine MaS/PCs (reviewed in [125, 126]). More 504 
recently, investigators have propagated non-adherent cells derived from bovine 505 
primary mammary epithelial cell cultures as mammospheres and after 11 days of 506 
selection have cultured cells derived from the mammospheres, a fraction anticipated 507 
to be enriched in MaS/PCs [127]. At present the functional properties of ruminant 508 
MaS/PCs that may confer reduced tumourigenic potential to the ruminant mammary 509 
gland remain undetermined. There may also be other factors also contributing to the 510 
apparent reduced tumour incidence in these species. 511 
 512 
For women under 20 years old, having a full term pregnancy is associated with a 513 
relative ‘protective’ effect against breast cancer equivalent to an approximately 50% 514 
risk reduction [128]. It may be postulated that production animals undergoing a first 515 
parity soon after puberty, and having multiple lactation cycles, may be subject to a 516 
similar decrease in mammary tumour risk associated with the effect of a full term 517 
pregnancy. This risk reduction may, for example, be the result of changes to the 518 
MaS/PCs that occur in association with late pregnancy or parturition. However, other 519 
authors have noted that the low incidence of mammary neoplasia appears to extend to 520 
ruminants maintained in zoos and other environments where they are not used for 521 
breeding, which would argue against this hypothesis [113]. 522 
 523 
A further consideration may be dietary: ruminants eat a high fibre, low fat diet 524 
whereas small domestic carnivores like cats have a diet more similar in composition 525 
to that of humans. Thus small domestic carnivores consume a diet that is not only 526 
higher in fat but may also lead to accumulation of more dietary carcinogens through 527 
the process of biomagnification [113, 129]. 528 
 529 
At present, the reasons for the rarity of mammary tumours in ruminants remain poorly 530 
understood. It is possible that this phenomenon may be multifactorial and that all the 531 
considerations described above are contributory factors. 532 
 533 
6.2. Feline mammary tumours as models for human breast cancer 534 
There has been longstanding recognition of the potential benefits of using feline 535 
mammary tumours as models for particular breast cancer subtypes [130] and several 536 
recent studies have further underlined this concept. Importantly, surrogate definitions 537 
of the intrinsic subtypes of human breast cancer can be generated by 538 
immunohistochemical measurements of oestrogen receptor, progesterone receptor, 539 
Ki-67 and HER2 [131]. When this St. Gallen International Expert Consensus Panel 540 
immunohistochemical classification of breast cancer subtypes was applied to feline 541 
mammary carcinomas, the most common feline subtype was the luminal B-542 
like/HER2-negative subtype (almost 30% of cases). The second most common feline 543 
subtype was the luminal B-like/HER2-positive group (approximately 20% of cases). 544 
Subtypes were associated with differing clinical and histological features, and 545 
survival times, and these associations frequently appeared to parallel those of human 546 
breast cancer. For example, the longest survival time was recorded with the luminal A 547 
subtype [132].  548 
 549 
The breast cancer intrinsic basal-like subtype and its triple-negative surrogate 550 
definition are not exact synonyms and show approximately 80% overlap [131]. Thus, 551 
some triple-negative breast cancers are not basal-like and are in fact one of the other 552 
intrinsic subtypes [133]. Similarly, in one study only 57% of feline triple-negative 553 
carcinomas were basal-like [132]. However, it is likely that the genuinely basal-like 554 
subgroup of the triple-negative feline mammary carcinomas may be a useful model 555 
for triple-negative breast cancers in women [134]. Interestingly, a recent study has 556 
demonstrated that the presence of large numbers of regulatory T cells, identified on 557 
the basis of FoxP3 expression, is a negative prognostic indicator in feline triple-558 
negative mammary carcinomas [135]. The authors therefore suggested that these 559 
tumours may be a useful model for the basal-like immune-suppressed subset of the 560 
triple-negative basal-like breast cancer group. This will require further molecular 561 
subtyping using a marker panel reflecting the accepted immunohistochemical profile 562 
of the basal-like immune-suppressed subset [136]. 563 
 564 
Any consideration of a potential tumour model requires a balanced assessment of the 565 
advantages and limitations. The cat is an attractive model, in part because cats 566 
frequently share the same environment as their owners [137], in some cases exhibit 567 
similar co-morbidities such as those associated with advanced age or obesity, and 568 
develop mammary tumours spontaneously. However, many pet cats undergo 569 
ovariohysterectomy at a young age, and this important difference needs to be 570 
considered in any evaluation of feline mammary tumours as a comparative model 571 
[109]. In addition, in contrast to the case in women, cats may frequently be presented 572 
with multiple mammary tumours and this causes difficulty in interpretation of results 573 
and comparison with breast cancer [132]. 574 
 575 
6.3. Rabbit mammary tumours  576 
Mammary tumours are regularly diagnosed in pet rabbits, particularly older non-577 
neutered females [138]. In one study examining rabbit surgical biopsy submissions to 578 
a German veterinary diagnostic laboratory, mammary tumours comprised 579 
approximately 20% of the submitted specimens [139]. The majority of these 580 
neoplasms are carcinomas, with smaller numbers of benign neoplasms reported [90, 581 
138, 139]. Recently, the presence of tumour infiltrating lymphocytes has been 582 
described in pet rabbit mammary carcinomas, with higher numbers of stromal 583 
lymphocytes present in central foci in neoplasms with a lower mitotic count and lower 584 
histological grade [140]. 585 
 586 
There are several facets of mammary tumourigenesis in rabbits that merit special 587 
mention. Several authors have presented evidence of the potential, in some but not all 588 
cases, for a continuum of tumour development from benign lesions, through in situ 589 
carcinomas, to overt carcinomas. Such evidence includes historic descriptions of a 590 
progression of tumour development from a benign neoplasm to an invasive carcinoma 591 
[141], the observation that benign neoplasms tend to be smaller and observed in 592 
younger animals [139], and the description of non-neoplastic entrapped myoepithelial 593 
cells within rabbit mammary carcinomas [142]. 594 
 595 
Interestingly, several morphological features of mammary carcinomas appear to be 596 
potentially more common in rabbits than in cats. Some tumours exhibit a notable 597 
degree of squamous differentiation leading them to be classified as adenosquamous, 598 
and squamous differentiation is also prominent in some ductal carcinomas [90, 139]. 599 
A vacuolated lipid rich mammary carcinoma variant is also described, and is 600 
postulated to reflect the high lipid content of rabbit milk [90, 139, 143, 144]. 601 
 602 
Rabbit mammary dysplasia or neoplasia may be influenced by hormones, particularly 603 
prolactin and oestrogen [138]. Prolactin-secreting pituitary adenomas have been 604 
reported in association with cystic mammary dysplasia in nine New Zealand white 605 
rabbit does [145] and, in a separate report, with mammary hyperplasia, dysplasia, and 606 
a cystic mammary adenocarcinoma [146]. Oestrogen receptor alpha and progesterone 607 
receptor expression have been documented in some benign rabbit mammary lesions, 608 
but it has been suggested that the majority of carcinomas do not exhibit expression of 609 
these steroid hormone receptors [143]. However, this data could be consistent with a 610 
role for steroid hormones acting as growth promoters, impacting early stages of rabbit 611 
mammary tumourigenesis. Mammary tumours may also be diagnosed in rabbits that 612 
are presented with uterine hyperplasia or adenocarcinoma, the latter a common 613 
tumour in this species [138, 144]. 614 
 615 
6.3.1. Rabbit mammary tumours as a model for human breast cancer 616 
We have documented the presence of sinus-like dilatations in the milk ducts of rabbits 617 
subjacent to the teat. Given the similarities to the human breast, including the 618 
presence of multiple galactophores per mamma, we have previously suggested that 619 
the rabbit mammary gland may represent a useful alternative model for the breast 620 
[89]. In parallel, other investigators have asserted that the rabbit may represent a 621 
model for administration of mammary intraductal treatments [147] and that rabbit 622 
mammary tumours may constitute a useful model for particular breast cancer subtypes 623 
[144]. There is therefore a compelling need for further research into the biology of the 624 
rabbit mammary gland, and particularly into the molecular characterization of rabbit 625 
mammary tumours [144]. The use of spontaneously occurring mammary tumours 626 
arising in pet rabbits as an additional breast cancer model is a potentially attractive 627 
prospect that should not be overlooked. In this regard the case of mammary tumours 628 
arising in house rabbits is particularly notable as these pets share a similar 629 
environment to their owners. 630 
 631 
7. Conclusions and future perspectives 632 
Studying mammary gland biology in species such as the sheep, cow, cat and rabbit is 633 
of dual interest. Firstly, mammary pathology arising in these species may severely 634 
compromise animal welfare or constitute a cause for euthanasia. Concomitantly, in 635 
farm animals mastitis may markedly affect productivity, with ensuing economic 636 
implications. There are therefore compelling reasons to focus on mammary pathology 637 
in these species. A further example of these species intrinsic drivers for research into 638 
mammary gland biology would be the recognition that mammary involution or the 639 
‘dry period’ in dairy cows constitutes a period of milk accumulation within the udder 640 
and thus a phase of increased risk of development of intramammary infections. One 641 
focus of current research is whether acceleration of involution might be beneficial in 642 
this species, balancing the need to reduce mastitis risk with the importance of the non-643 
milking period as a time of cellular renewal [148]. 644 
 645 
Beyond these species intrinsic drivers for mammary research, comparative mammary 646 
biology promotes a wider awareness of similarities and differences between species in 647 
terms of mammary development, microenvironment, and tumourigenesis. Such an 648 
appreciation underpins the One Health narrative in which the study of non-traditional 649 
model species increases our understanding of mammary development and disease in 650 
humans and animals. As has been noted elsewhere, laboratory rodents provide 651 
extremely tractable models, but there are important species differences between the 652 
rodent mammary gland and the human breast [1, 3, 26]. The study of non-traditional 653 
model species, particularly in the context of mammary development and 654 
spontaneously occurring natural disease, may provide new insights that are 655 
translatable to the human breast and are of benefit to both humans and animals. 656 
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 1108 
Figure legends 1109 
Figure 1. The ovine mammary postnatal developmental cycle. Histological 1110 
sections of mammary gland from a neonatal lamb (A), ewe in early lactation (B), ewe 1111 
at point of lamb removal following a degree of natural weaning (C), and ewe 4 weeks 1112 
post lamb removal (D). Note the clear demarcation between intra- and interlobular 1113 
stroma in the neonatal lamb (arrowheads). A notable degree of post-lactational 1114 
regression has occurred at the point of weaning, reflecting natural weaning in an 1115 
agricultural system. Mineralised concretions (corpora amylacea) (asterisks) are a 1116 
common feature of the ruminant mammary gland. Haematoxylin and eosin stain. 1117 
Scale bar indicates 200 microns. 1118 
 1119 
Figure 2. Binucleated cells are present in the bovine mammary gland in late 1120 
gestation. Immunofluorescence staining for E-cadherin (magenta), α-smooth muscle 1121 
actin (α-SMA; cyan), and DNA (DAPI; gold) in a bovine mammary gland at 250 days 1122 
gestation (bovine gestation length is approximately 283 days). A likely binucleated 1123 
luminal epithelial cell is indicated (arrow). Scale bar indicates 50 microns. 1124 
 1125 
Figure 3. Feline tubulopapillary carcinoma. Immunofluorescence staining for E-1126 
cadherin (magenta), IBA1 (macrophages; cyan) (arrows), and DNA (DAPI; gold) in a 1127 
feline tubulopapillary carcinoma. Arrowhead indicates papillary projections of 1128 
neoplastic cells. Scale bar indicates 50 microns. 1129 
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